Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease

被引:52
|
作者
El Tayara, NE
Delatour, B
Le Cudennec, C
Guégan, M
Volk, A
Dhenain, M [1 ]
机构
[1] Ctr Univ, INSERM, Inst Curie, Integrat Imaging Unit,Lab 112, F-91405 Orsay, France
[2] Univ Paris 11, UMR 8620, CNRS, Lab NAMC, F-91405 Orsay, France
关键词
Alzheimer's disease; amyloid; APP; biomarker; iron; MRI; PS1; T1; T2; transgenic mouse;
D O I
10.1016/j.nbd.2005.10.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
T1 and T2 magnetic resonance relaxation times have the potential to provide biomarkers of amyloid-beta deposition that could be helpful to the development of new therapies for Alzheimer's disease. Here, we measured T1 and T2 times as well as plaques and iron loads in APP/PS1 mice, which model brain amyloidosis, and control PS1 mice. Iron was mostly associated with amyloid deposits in APP/PS1 animals, while it was diffuse in the PS1 mice. T1 was negatively correlated with age in most structures in APP/PS1 animals. This may be related to the age-associated myelin loss described in APP/PS1 mice rather than to amyloid deposition. T2 in the subiculum of adult APP/PS1 animals was lower than in PS1 mice, which may be related to the very high amyloid and iron loads in this region. T2 in the subiculum could thus serve as an early marker of the amyloid pathology. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:199 / 208
页数:10
相关论文
共 50 条
  • [41] Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease
    Matsuoka, Y
    Picciano, M
    La Francois, J
    Duff, K
    NEUROSCIENCE, 2001, 104 (03) : 609 - 613
  • [42] MR Microimaging of amyloid plaques in Alzheimer's disease transgenic mice
    Wengenack, Thomas M.
    Jack, Clifford R., Jr.
    Garwood, Michael
    Poduslo, Joseph F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (Suppl 1) : S82 - S88
  • [43] Nasal administration of amyloid β-peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease
    Weiner, HL
    Lemere, CA
    Maron, R
    Spooner, ET
    Crenfell, TJ
    Mori, C
    Issazadeh, S
    Hancock, WW
    Selkoe, DJ
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 415 - 415
  • [44] Olfactory Dysfunction Correlates with Amyloid-β Burden in an Alzheimer's Disease Mouse Model
    Wesson, Daniel W.
    Levy, Efrat
    Nixon, Ralph A.
    Wilson, Donald A.
    JOURNAL OF NEUROSCIENCE, 2010, 30 (02): : 505 - 514
  • [45] Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model
    Rakoczy, PE
    Zhang, D
    Robertson, T
    Barnett, NL
    Papadimitriou, J
    Constable, IJ
    Lai, CM
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04): : 1515 - 1524
  • [46] Age-related changes in social behaviours in the 5xFAD mouse model of Alzheimer's disease
    Kosel, Filip
    Munoz, Paula Torres
    Yang, J. Renee
    Wong, Aimee A.
    Franklin, Tamara B.
    BEHAVIOURAL BRAIN RESEARCH, 2019, 362 : 160 - 172
  • [47] Pyroglutamate Amyloid β (Aβ) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease
    Wittnam, Jessica L.
    Portelius, Erik
    Zetterberg, Henrik
    Gustavsson, Mikael K.
    Schilling, Stephan
    Koch, Birgit
    Demuth, Hans-Ulrich
    Blennow, Kaj
    Wirths, Oliver
    Bayer, Thomas A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (11) : 8154 - 8162
  • [48] Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
    DeMattos, RB
    Bales, KR
    Cummins, DJ
    Paul, SM
    Holtzman, DM
    SCIENCE, 2002, 295 (5563) : 2264 - 2267
  • [49] Transplanted Astrocytes internalize deposited β-amyloid peptides in a transgenic mouse model of Alzheimer's disease
    Pihlaja, Rea
    Koistinaho, Jari
    Malm, Tarja
    Sikkila, Herkko
    Vainio, Seppo
    Koistinaho, Milla
    GLIA, 2008, 56 (02) : 154 - 163
  • [50] Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease
    Weiner, HL
    Lemere, CA
    Maron, R
    Spooner, ET
    Grenfell, TJ
    Mori, C
    Issazdeh, S
    Hancock, WW
    Selkoe, DJ
    ANNALS OF NEUROLOGY, 2000, 48 (04) : 567 - 579